CVS Health

Cordavis Launches First Biosimilar: Novartis’ Hyrimoz to Compete with Humira

Swiss pharmaceutical giant Novartis (NYSE: NVS) unit Sandoz’s biosimilar product, Hyrimoz (adalimumab), which references AbbVie’s...